Terms: = Colorectal cancer AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
426 results:
1. Immune checkpoint inhibitors in cancer patients with rheumatologic preexisting autoimmune diseases: a systematic review and meta-analysis.
Liu X; Li S; Ke L; Cui H
BMC Cancer; 2024 Apr; 24(1):490. PubMed ID: 38632528
[TBL] [Abstract] [Full Text] [Related]
2. Uncommon using of the pulmonary homograft in oncological case - three years follow up.
Lahidheb D; Komarov R; Alikhanov R; Tlisov B; Ismailbaev A; Dhif I
J Cardiothorac Surg; 2024 Apr; 19(1):204. PubMed ID: 38615010
[TBL] [Abstract] [Full Text] [Related]
3. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
[TBL] [Abstract] [Full Text] [Related]
4. A metabolomics approach reveals metabolic disturbance of human cholangiocarcinoma cells after parthenolide treatment.
He Y; Yu Q; Ma X; Lv D; Wang H; Qiu W; Chen XF; Jiao Y; Liu Y
J Ethnopharmacol; 2024 Jun; 328():118075. PubMed ID: 38513779
[TBL] [Abstract] [Full Text] [Related]
5. Expanding MELD exceptions for colorectal liver metastasis: data and policy.
Whitrock JN; Pratt CG; Shah SA
Curr Opin Organ Transplant; 2024 Jun; 29(3):195-199. PubMed ID: 38483122
[TBL] [Abstract] [Full Text] [Related]
6. Physical activity for cancer prehabilitation: A scoping review.
Yang L; Alice A; Friedenreich CM
Crit Rev Oncol Hematol; 2024 Apr; 196():104319. PubMed ID: 38460927
[TBL] [Abstract] [Full Text] [Related]
7. Tumor-targeted delivery of copper-manganese biomineralized oncolytic adenovirus for colorectal cancer immunotherapy.
Li YS; Ye LY; Luo YX; Zheng WJ; Si JX; Yang X; Zhang YN; Wang SB; Zou H; Jin KT; Ge T; Cai Y; Mou XZ
Acta Biomater; 2024 Apr; 179():243-255. PubMed ID: 38458511
[TBL] [Abstract] [Full Text] [Related]
8. Ethyl acetate fraction of Osmanthus fragrans var. aurantiacus and its triterpenoids suppress proliferation and survival of colorectal cancer cells by inhibiting NF-κB and COX2.
Han S; Lim SL; Kim H; Choi H; Lee MY; Shim SY; Le DD; Ha IJ; Lee M; Lee SG
J Ethnopharmacol; 2024 Jan; 319(Pt 3):117362. PubMed ID: 38380575
[TBL] [Abstract] [Full Text] [Related]
9. Ethyl cinnamate suppresses tumor growth through anti-angiogenesis by attenuating VEGFR2 signal pathway in colorectal cancer.
Wang S; Yang J; Kuang X; Li H; Du H; Wu Y; Xu F; Liu B
J Ethnopharmacol; 2024 May; 326():117913. PubMed ID: 38360380
[TBL] [Abstract] [Full Text] [Related]
10. Villosol reverses 5-FU resistance in colorectal cancer by inhibiting the CDKN2A gene regulated TP53-PI3K/Akt signaling axis.
Chen H; Deng J; Hou TW; Shan YQ
J Ethnopharmacol; 2024 May; 325():117907. PubMed ID: 38342156
[TBL] [Abstract] [Full Text] [Related]
11. Herbal medicine for the prevention of chemotherapy-induced nausea and vomiting in patients with advanced colorectal cancer: A prospective randomized controlled trial.
Wu Z; Fu X; Jing H; Huang W; Li X; Xiao C; Li Z; You F
J Ethnopharmacol; 2024 May; 325():117853. PubMed ID: 38341113
[TBL] [Abstract] [Full Text] [Related]
12. A pH-responsive cetuximab-conjugated DMAKO-20 nano-delivery system for overcoming K-ras mutations and drug resistance in colorectal carcinoma.
Song H; Li H; Shen X; Liu K; Feng H; Cui J; Wei W; Sun X; Fan Q; Bao W; Zhou H; Qian L; Nie H; Cheng X; Du Z
Acta Biomater; 2024 Mar; 177():456-471. PubMed ID: 38331131
[TBL] [Abstract] [Full Text] [Related]
13. PROGNOSTIC SIGNIFICANCE OF microRNA-100, -125b, AND -200b IN PATIENTS WITH colorectal cancer.
Maliborska S; Holotiuk V; Partykevych Y; Rossylna O
Exp Oncol; 2024 Feb; 45(4):443-450. PubMed ID: 38328846
[TBL] [Abstract] [Full Text] [Related]
14. Robotic beyond total mesorectal excision (TME) for locally advanced or recurrent rectal cancer: a systematic review protocol.
Panagiotopoulou IG; Przedlacka A; Piozzi GN; Mills GA; Harper M; Khan JS
BMJ Open; 2024 Jan; 14(1):e080043. PubMed ID: 38272558
[TBL] [Abstract] [Full Text] [Related]
15. Elderly Rectal cancer: An Updated Review.
Huang CK; Shih CH; Kao YS
Curr Oncol Rep; 2024 Feb; 26(2):181-190. PubMed ID: 38270849
[TBL] [Abstract] [Full Text] [Related]
16. Iatrogenic ureteral injury: What should the digestive surgeon know?
Souli A; Alves A; Tillou X; Menahem B
J Visc Surg; 2024 Feb; 161(1):6-14. PubMed ID: 38242812
[TBL] [Abstract] [Full Text] [Related]
17. HLA class II polymorphisms as prognostic biomarkers for right and left-sided colon cancer.
Attia A; Lagha A; Mezlini A; Ghazouani E; Yacoubi-Loueslati B; Namouchi I
Int J Biol Markers; 2024 Mar; 39(1):40-51. PubMed ID: 38179594
[TBL] [Abstract] [Full Text] [Related]
18. cancer survivor late-effects, chronic health problems after cancer treatment: what's the evidence from population and registry data and where are the gaps?
Faithfull S; Greenfield D
Curr Opin Support Palliat Care; 2024 Mar; 18(1):55-64. PubMed ID: 38170192
[TBL] [Abstract] [Full Text] [Related]
19. Overcoming multi drug resistance mediated by ABC transporters by a novel acetogenin- annonacin from Annona muricata L.
Manoharan JP; Palanisamy H; Vidyalakshmi S
J Ethnopharmacol; 2024 Mar; 322():117598. PubMed ID: 38113989
[TBL] [Abstract] [Full Text] [Related]
20. Investigating the pharmacological mechanism of Zhengyuan jiaonang for treating colorectal cancer via network pharmacology analysis and experimental verification.
Deng H; Liu S; Li D; Wang W; Ye L; Xu S; Wang X; Li Y
J Ethnopharmacol; 2024 Mar; 322():117607. PubMed ID: 38110132
[TBL] [Abstract] [Full Text] [Related]
[Next]
